Chronic gastric electrical stimulation leads to weight loss via modulating multiple tissue neuropeptide Y, orexin, α-melanocyte-stimulating hormone and oxytocin in obese rats

References

• Jensen MD, Ryan DH. New obesity guidelines: promise and potential. JAMA 2014;311:23–4.
   PubMed Web of Science ®Google Scholar
• Cha R, Marescaux J, Diana M. Updates on gastric electrical stimulation to treat obesity: Systematic review and future perspectives. World J Gastrointest Endosc 2014;6:419–31.
   PubMedGoogle Scholar
• Chiu JD, Soffer E. Gastric electrical stimulation for obesity. Curr Gastroenterol Rep 2015;17:424.
   PubMedGoogle Scholar
• Shikora SA. Implantable gastric stimulation for weight loss. J Gastrointest Surg 2004;8:408–12.
   PubMed Web of Science ®Google Scholar
• Shikora SA, Bergenstal R, Bessler M, Brody F, Foster G, Frank A, et al. Implantable gastric stimulation for the treatment of clinically severe obesity: results of the SHAPE trial. Surg Obes Relat Dis 2009;5:31–7.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Du S, Fang L, Yao S, Chen JD. Retrograde gastric electrical stimulation suppresses calorie intake in obese subjects. Obesity (Silver Spring) 2014;22:1447–51.
   PubMed Web of Science ®Google Scholar
• Horbach T, Thalheimer A, Seyfried F, Eschenbacher F, Schuhmann P, Meyer G. abiliti closed-loop gastric electrical stimulation system for treatment of obesity: clinical results with a 27-month follow-up. Obes Surg 2015. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Miras M, Serrano M, Duran C, Valino C, Canton S. Early experience with customized, meal-triggered gastric electrical stimulation in obese patients. Obes Surg 2015;25:174–9.
   PubMed Web of Science ®Google Scholar
• Kalra SP, Kalra PS. NPY and cohorts in regulating appetite, obesity and metabolic syndrome: beneficial effects of gene therapy. Neuropeptides 2004;38:201–11.
   PubMed Web of Science ®Google Scholar
• Cone RD. Studies on the physiological functions of the melanocortin system. Endocr Rev 2006;27:736–49.
   PubMed Web of Science ®Google Scholar
• Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998;92:1.
   PubMed Web of Science ®Google Scholar
• Olson BR, Drutarosky MD, Chow MS, Hruby VJ, Stricker EM, Verbalis JG. Oxytocin and an oxytocin agonist administered centrally decrease food intake in rats. Peptides 1991;12:113–18.
   PubMed Web of Science ®Google Scholar
• Scherer PE. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006;55:1537–45.
   PubMed Web of Science ®Google Scholar
• Yang K, Guan H, Arany E, Hill DJ, Cao X. Neuropeptide Y is produced in visceral adipose tissue and promotes proliferation of adipocyte precursor cells via the Y1 receptor. FASEB J 2008;22:2452–64.
   PubMed Web of Science ®Google Scholar
• Kuo LE, Kitlinska JB, Tilan JU, Li L, Baker SB, Johnson MD, et al. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med 2007;13:803–11.
   PubMed Web of Science ®Google Scholar
• Perez-Leighton CE, Billington CJ, Kotz CM. Orexin modulation of adipose tissue. Biochim Biophys Acta 2014;1842:440–5.
   PubMed Web of Science ®Google Scholar
• Skrzypski M, T Le T, Kaczmarek P, Pruszynska-Oszmalek E, Pietrzak P, Szczepankiewicz D, et al. Orexin A stimulates glucose uptake, lipid accumulation and adiponectin secretion from 3T3-L1 adipocytes and isolated primary rat adipocytes. Diabetologia 2011;54:1841–52.
   PubMed Web of Science ®Google Scholar
• Nogueiras R, Wiedmer P, Perez-Tilve D, Veyrat-Durebex C, Keogh JM, Sutton GM, et al. The central melanocortin system directly controls peripheral lipid metabolism. J Clin Invest 2007;117:3475–88.
   PubMed Web of Science ®Google Scholar
• Rodrigues AR, Almeida H, Gouveia AM. Alpha-MSH signalling via melanocortin 5 receptor promotes lipolysis and impairs re-esterification in adipocytes. Biochim Biophys Acta 2013;1831:1267–75.
   PubMed Web of Science ®Google Scholar
• Deblon N, Veyrat-Durebex C, Bourgoin L, Caillon A, Bussier AL, Petrosino S, et al. Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats. PLoS ONE 2011;6:e25565.
   PubMed Web of Science ®Google Scholar
• Takayanagi Y, Kasahara Y, Onaka T, Takahashi N, Kawada T, Nishimori K. Oxytocin receptor-deficient mice developed late-onset obesity. Neuroreport 2008;19:951–5.
   PubMed Web of Science ®Google Scholar
• Xing J, Chen JD. Alterations of gastrointestinal motility in obesity. Obes Res 2004;12:1723–32.
   PubMedGoogle Scholar
• Matsuda M, Aono M, Moriga M, Okuma M. Centrally administered neuropeptide Y (NPY) inhibits gastric emptying and intestinal transit in the rat. Dig Dis Sci 1993;38:845–50.
   PubMed Web of Science ®Google Scholar
• Wu CL, Hung CR, Chang FY, Pau KY, Wang PS. Pharmacological effects of oxytocin on gastric emptying and intestinal transit of a non-nutritive liquid meal in female rats. Naunyn Schmiedebergs Arch Pharmacol 2003;367:406–13.
   PubMed Web of Science ®Google Scholar
• Kirchgessner AL, Liu M. Orexin synthesis and response in the gut. Neuron 1999;24:941–51.
   PubMed Web of Science ®Google Scholar
• Xu J, McNearney TA, Chen JD. Gastric/intestinal electrical stimulation modulates appetite regulatory peptide hormones in the stomach and duodenum in rats. Obes Surg 2007;17:406–13.
   PubMed Web of Science ®Google Scholar
• Yan Y, Xiang XL, Qian W, Xu JY, Hou XH. Changes of neuronal activities after gut electrical stimulation with different parameters and locations in lateral hypothalamus area of obese rats. J Huazhong Univ Sci Technolog Med Sci 2014;34:510–15.
   PubMed Web of Science ®Google Scholar
• Zhang J, Maude-Griffin R, Zhu H, Sun Y, Starkebaum W, Firestone E, et al. Gastric electrical stimulation parameter dependently alters ventral medial hypothalamic activity and feeding in obese rats. Am J Physiol Gastrointest Liver Physiol 2011;301:G912–18.
   PubMed Web of Science ®Google Scholar
• Li S, Maude-Griffin R, Sun Y, Starkebaum W, Chen JD. Food intake and body weight responses to intermittent vs. continuous gastric electrical stimulation in diet-induced obese rats. Obes Surg 2013;23:71–9.
   PubMed Web of Science ®Google Scholar
• El-Salhy M. Gastric emptying in an animal model of human diabetes type 1: relation to endocrine cells. Acta Diabetol 2001;38:139–44.
   PubMed Web of Science ®Google Scholar
• Tang M, Zhang J, Xu L, Chen JD. Implantable gastric stimulation alters expression of oxytocin- and orexin-containing neurons in the hypothalamus of rats. Obes Surg 2006;16:762–9.
   PubMed Web of Science ®Google Scholar
• Cigaina V, Hirschberg AL. Gastric pacing for morbid obesity: plasma levels of gastrointestinal peptides and leptin. Obes Res 2003;11:1456–62.
   PubMedGoogle Scholar
• Zhang J, Liu S, Tang M, Chen JD. Optimal locations and parameters of gastric electrical stimulation in altering ghrelin and oxytocin in the hypothalamus of rats. Neurosci Res 2008;62:262–9.
   PubMed Web of Science ®Google Scholar
• Peles S, Petersen J, Aviv R, Policker S, Abu-Hatoum O, Ben-Haim SA, et al. Enhancement of antral contractions and vagal afferent signaling with synchronized electrical stimulation. Am J Physiol Gastrointest Liver Physiol 2003;285:G577–85.
   PubMed Web of Science ®Google Scholar
• Qin C, Sun Y, Chen JD, Foreman RD. Gastric electrical stimulation modulates neuronal activity in nucleus tractus solitarii in rats. Auton Neurosci 2005;119:1–8.
   PubMed Web of Science ®Google Scholar
• Ouyang H, Yin J, Chen JD. Therapeutic potential of gastric electrical stimulation for obesity and its possible mechanisms: a preliminary canine study. Dig Dis Sci 2003;48:698–705.
   PubMed Web of Science ®Google Scholar
• Sohn JW, Elmquist JK, Williams KW. Neuronal circuits that regulate feeding behavior and metabolism. Trends Neurosci 2013;36:504–12.
   PubMed Web of Science ®Google Scholar
• Sucajtys-Szulc E, Turyn J, Goyke E, Korczynska J, Stelmanska E, Slominska E, et al. Differential effect of prolonged food restriction and fasting on hypothalamic malonyl-CoA concentration and expression of orexigenic and anorexigenic neuropeptides genes in rats. Neuropeptides 2010;44:17–23.
   PubMed Web of Science ®Google Scholar
• Shi YC, Baldock PA. Central and peripheral mechanisms of the NPY system in the regulation of bone and adipose tissue. Bone 2012;50:430–6.
   PubMed Web of Science ®Google Scholar
• Digby JE, Chen J, Tang JY, Lehnert H, Matthews RN, Randeva HS. Orexin receptor expression in human adipose tissue: effects of orexin-A and orexin-B. J Endocrinol 2006;191:129–36.
   PubMed Web of Science ®Google Scholar
• Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev 2001;81:629–83.
   PubMed Web of Science ®Google Scholar
• Shi YC, Lin S, Castillo L, Aljanova A, Enriquez RF, Nguyen AD, et al. Peripheral-specific y2 receptor knockdown protects mice from high-fat diet-induced obesity. Obesity (Silver Spring) 2011;19:2137–48.
   PubMed Web of Science ®Google Scholar
• Wright RA, Krinsky S, Fleeman C, Trujillo J, Teague E. Gastric emptying and obesity. Gastroenterology 1983;84:747–51.
   PubMed Web of Science ®Google Scholar
• Ehrstrom M, Gustafsson T, Finn A, Kirchgessner A, Gryback P, Jacobsson H, et al. Inhibitory effect of exogenous orexin a on gastric emptying, plasma leptin, and the distribution of orexin and orexin receptors in the gut and pancreas in man. J Clin Endocrinol Metab 2005;90:2370–7.
   PubMed Web of Science ®Google Scholar
• Wang YN, McDonald JK, Wyatt RJ. Immunocytochemical localization of neuropeptide Y-like immunoreactivity in adrenergic and non-adrenergic neurons of the rat gastrointestinal tract. Peptides 1987;8:145–51.
   PubMed Web of Science ®Google Scholar
• Ohlsson B, Truedsson M, Djerf P, Sundler F. Oxytocin is expressed throughout the human gastrointestinal tract. Regul Pept 2006;135:7–11.
   PubMed Web of Science ®Google Scholar